p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells

Nature Medicine

Volumn 4, Issue 12, 1998, Pages 1371-1376

  Ambs, Stefan ^a   Merriam, William G ^a   Ogunfusika, Mofolusara O ^a   Bennett, William P ^a   Ishibe, Naoko ^a   Hussain, S Perwez ^a   Tzeng, Edith E ^b   Geller, David A ^b   Billiar, Timothy R ^b   Harris, Curtis C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; NITRIC OXIDE SYNTHASE; PROTEIN P53; VASCULOTROPIN;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER; CANCER CELL; CARCINOGENESIS; HUMAN; HUMAN CELL; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ANIMALS; ANTIGENS, CD31; APOPTOSIS; ENDOTHELIAL GROWTH FACTORS; GENE TRANSFER TECHNIQUES; HUMANS; LYMPHOKINES; MICE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA; MUS MUSCULUS;

EID: 0031728358     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/3957     Document Type: Article

References (33)

1. Thomsen, L.L. et al. Nitric oxide synthase activity in human breast cancer. Br. J. Cancer 72, 41-44 (1995).
2. Ellie, E., Loiseau, H., Lafond, F., Arsaut, J. & Demotes-Mainard, J. Differential expression of inducible nitric oxide synthase mRNA in human brain tumors. Neuroreport 7, 294-296 (1995).
3. Ambs, S. et al. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res. 58, 334-341 (1998).
4. Gallo, O. et al. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J. Natl. Cancer Inst. 90, 587-596 (1998).
5. Thomsen, L.L. et al. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Cancer Res. 57, 3300-3304 (1997).
6. Melillo, G. et al. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J. Exp. Med. 182, 1683-1693 (1995).
7. Ziche, M. et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor - induced but not basic fibroblast growth factor-induced angiogenesis. J. Clin. Invest. 99, 2625-2634 (1997).
8. Chin, K. et al. Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells. Oncogene 15, 437-442 (1997).
9. Jenkins, D.C. et al. Roles of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. USA 92, 4392-4396 (1995).
10. Edwards, P. et al. Tumor cell nitric oxide inhibits cell growth in vitro, but stimulates tumorigenesis and experimental lung metastasis in vivo. J. Surg. Res. 63, 49-52 (1996).
11. Garcia-Cardena, G. & Folkman, J. Is there a role for nitric oxide in tumor angiogenesis? J. Natl. Cancer Inst. 90, 560-561 (1998).
12. Dong, Z., Staroselsky, A.M., Qi, X., Xie, K. & Fidler, I.J. Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res. 54, 789-793 (1994).
13. Xie, K. et al. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J. Exp. Med. 181, 1333-1343 (1995).
14. Geng, Y.J., Hellstrand, K., Wennmalm, A. & Hansson, G.K. Apoptotic death of human leukemic cells induced by vascular cells expressing nitric oxide synthase in response to gamma-interferon and tumor necrosis factor-alpha. Cancer Res. 56, 866-874 (1996).
15. Nicotera, P., Bonfoco, E. & Brune, B. Mechanisms for nitric oxide-induced cell death: involvement of apoptosis. Adv. Neuroimmunol. 5, 411-420 (1997).
16. Kim, Y.M., Talanian, R.V. & Billiar, T.R. Nitric oxide inhibits apoptosis. J. Biol. Chem. 272, 1402-1411 (1997).
17. Mannick, J.B., Miao, X.Q. & Stamler, J.S. Nitric oxide inhibits Fas-induced apoptosis. J. Biol. Chem. 272, 24125-24128 (1997).
18. Messmer, U.K. & Brune, B. Nitric oxide-induced apoptosis: p53-dependent and p53-independent signalling pathways. Biochem. J. 319, 299-305 (1996).
19. Forrester, K. et al. Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase (NOS2) expression by wild-type p53. Proc. Natl. Acad. Sci. USA 93, 2442-2447 (1996).
20. Tzeng, E., Billiar, T.R., Robbins, P.D., Loftus, M. & Stuehr, D.J. Expression of human inducible NO synthase in a tetrahydrobiopterin promotes assembly of enzyme subunits into an active dimer. Proc. Natl. Acad. Sci. USA 92, 11771-11775 (1995).
21. Lewis, R.S., Tamir, S., Tannenbaum, S.R. & Deen, W.M. Kinetic analysis of the fate of nitric oxide synthesized by macrophages in vitro. J. Biol. Chem. 270, 29350-29355 (1995).
22. Polyak, K., Waldman, T., He, T.C., Kinzler, K.W. & Vogelstein, B. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 10, 1945-1952 (1996).
23. Griffiths, M.J., Messent, M., MacAllister, R.J. & Evans, T.W. Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br. J. Pharmacol. 110, 963-968 (1993).
24. Vermeulen, P.B. et al. Correlation of intratumoral microvessel density and p53 protein overexpression in human colorectal adenocarcinoma. Microvasc. Res. 51, 164-174 (1996).
25. Hentze, M.W. & Kuhn, L.C. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc. Natl. Acad. Sci. USA 93, 8175-8182 (1996).
26. Gleadle, J.M., Ebert, B.L., Firth, J.D. & Ratcliffe, P.J. Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents. Am. J. Physiol. 268, C1362-8 (1995).
27. Piazza, G.A. et al. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res. 55, 3110-3116 (1995).
28. Tsurumi, Y. et al. Reciprocal relation between VECF and NO in the regulation of endothelial integrity. Nature Med. 3, 879-886 (1997).
29. Dameron, K.M., Volpert, O.V., Tainsky, M.A. & Bouck, N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265, 1582-1584 (1994).
30. Greenblatt, M.S., Bennett, W.P., Hollstein, M. & Harris, C.C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54, 4855-4878 (1994).
31. Ambs, S., Hussain, S.P. & Harris, C.C. Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J. 11, 443-448 (1997).
32. Geller, D.A. et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc. Natl. Acad. Sci. USA 90, 3491-3495 (1993).
33. Rak, J. et al. Mutant ras oncogenes upregulate VECF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res. 55, 4575-4580 (1995).